Zimbabwe approves long-acting HIV prevention injection | The Herald (Top Stories) Sunday Mail Reporter ZIMBABWE has approved ...

African kingdom has accepted 15 men as part of a third-country deportation program. This program, which has been strongly ...

But the rollout is now being wielded as a political tool. What that “America First” slogan actually means for global health ...

Patient advocacy groups urged the South African government to issue a compulsory license for a groundbreaking HIV prevention ...

You can now be vaccinated against HIV – but that does not mean you can be reckless, warns the Department of Health ...

Eswatini has become the first African country to receive lenacapavir, a twice-yearly HIV prevention injection that global ...

About 1,000 doses of Gilead Sciences Inc's drug lenacapavir were delivered to Zambia and Eswatini last Thursday, U.S. and ...

The drug lenacapavir will be distributed to Eswatini and Zambia — the first step toward providing at least 2 million doses to ...

The United States said Tuesday it has delivered a new treatment to prevent HIV in two African countries, months after President Donald Trump dramatically cut global aid.

Oct 30 (Reuters) - Gilead Sciences (GILD.O), opens new tab said on Thursday its HIV drug sales rose 4% to $5.3 billion in the third quarter including $39 million for its new prevention drug Yeztugo, ...

(Reuters) -Gilead Sciences said on Thursday its HIV drug sales rose 4% to $5.3 billion in the third quarter including $39 million for its new prevention drug Yeztugo, helping to boost its profit.

Pricing issues have taken precedence as CVS Health’s (NYSE:CVS) pharmacy benefit manager, CVS Caremark, continues to hold off adding Yeztugo, Gilead Sciences’ (NASDAQ:GILD) new HIV prevention drug, to ...